These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 27650643)

  • 1. The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model.
    Chakhtoura M; Leslie WD; McClung M; Cheung AM; Fuleihan GE
    Osteoporos Int; 2017 Jan; 28(1):127-137. PubMed ID: 27650643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.
    Kanis JA; Harvey NC; Cooper C; Johansson H; Odén A; McCloskey EV;
    Arch Osteoporos; 2016 Dec; 11(1):25. PubMed ID: 27465509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FRAX- vs. T-score-based intervention thresholds for osteoporosis.
    Johansson H; Azizieh F; Al Ali N; Alessa T; Harvey NC; McCloskey E; Kanis JA
    Osteoporos Int; 2017 Nov; 28(11):3099-3105. PubMed ID: 28782072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FRAX-based intervention and assessment thresholds for osteoporosis in Iran.
    Khashayar P; Keshtkar A; Ostovar A; Larijani B; Johansson H; Harvey NC; Lorentzon M; McCloskey E; Kanis JA
    Osteoporos Int; 2019 Nov; 30(11):2225-2230. PubMed ID: 31372709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FRAX® based intervention thresholds for management of osteoporosis in Singaporean women.
    Chandran M; McCloskey EV; Thu WPP; Logan S; Hao Y; Tay D; Ang WC; Aung TKK; Choo KS; Ali A; Yan SX; Huang XF; Liu XM; Yong EL; Lekamwasam S
    Arch Osteoporos; 2018 Nov; 13(1):130. PubMed ID: 30456726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.
    Kanis JA; McCloskey EV; Johansson H; Strom O; Borgstrom F; Oden A;
    Osteoporos Int; 2008 Oct; 19(10):1395-408. PubMed ID: 18751937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revised FRAX®-based intervention thresholds for the management of osteoporosis among postmenopausal women in Sri Lanka.
    Lekamwasam S; Chandran M; Subasinghe S
    Arch Osteoporos; 2019 Mar; 14(1):33. PubMed ID: 30850909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women.
    Chandran M; Ganesan G; Tan KB; Reginster JY; Hiligsmann M
    Osteoporos Int; 2021 Jan; 32(1):133-144. PubMed ID: 32797250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of FRAX and FRAX-Based Treatment Thresholds in Women Aged 40 Years and Older: The Manitoba BMD Registry.
    Crandall CJ; Schousboe JT; Morin SN; Lix LM; Leslie W
    J Bone Miner Res; 2019 Aug; 34(8):1419-1427. PubMed ID: 30920022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FRAX-based intervention and assessment thresholds for osteoporosis in Romania.
    Grigorie D; Sucaliuc A; Johansson H; Kanis JA; McCloskey E
    Arch Osteoporos; 2013; 8():164. PubMed ID: 24390553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of the Brazilian Fracture Assessment Risk Tool (FRAX) model and the age-dependent intervention thresholds according to National Osteoporosis Guideline Group (NOGG) guidelines on fracture prediction in community-dwelling older adults: the São Paulo Ageing and Health (SPAH) Study.
    Freitas TQ; Olalla LFG; Machado LG; Figueiredo CP; Takayama L; de Falco Caparbo V; Domiciano DS; Pereira RMR
    Arch Osteoporos; 2024 Jul; 19(1):59. PubMed ID: 38990403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of spine-hip discordance on fracture risk assessment and treatment qualification in Canada: the Manitoba BMD registry.
    Leslie WD; Morin SN; Lix LM; Binkley N
    Arch Osteoporos; 2020 Jun; 15(1):85. PubMed ID: 32514615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effective osteoporosis treatment thresholds in Greece.
    Makras P; Athanasakis K; Boubouchairopoulou N; Rizou S; Anastasilakis AD; Kyriopoulos J; Lyritis GP
    Osteoporos Int; 2015 Jul; 26(7):1949-57. PubMed ID: 25740208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoporosis treatment considerations based upon fracture history, fracture risk assessment, vertebral fracture assessment, and bone density in Canada.
    Leslie WD; Lix LM; Binkley N
    Arch Osteoporos; 2020 Jun; 15(1):93. PubMed ID: 32577922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland.
    Lippuner K; Johansson H; Borgström F; Kanis JA; Rizzoli R
    Osteoporos Int; 2012 Nov; 23(11):2579-89. PubMed ID: 22222755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment thresholds for osteoporosis in men on androgen deprivation therapy: T-score versus FRAX.
    Adler RA; Hastings FW; Petkov VI
    Osteoporos Int; 2010 Apr; 21(4):647-53. PubMed ID: 19533207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishing and evaluating FRAX
    Chan DC; McCloskey EV; Chang CB; Lin KP; Lim LC; Tsai KS; Yang RS
    J Formos Med Assoc; 2017 Mar; 116(3):161-168. PubMed ID: 27117886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FRAX-based intervention and assessment thresholds in seven Latin American countries.
    Clark P; Denova-Gutiérrez E; Zerbini C; Sanchez A; Messina O; Jaller JJ; Campusano C; Orces CH; Riera G; Johansson H; Kanis JA
    Osteoporos Int; 2018 Mar; 29(3):707-715. PubMed ID: 29273826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FRAX-based assessment and intervention thresholds--an exploration of thresholds in women aged 50 years and older in the UK.
    McCloskey E; Kanis JA; Johansson H; Harvey N; Odén A; Cooper A; Cooper C; Francis RM; Reid DM; Marsh D; Selby P; Thompson F; Hewitt S; Compston J
    Osteoporos Int; 2015 Aug; 26(8):2091-9. PubMed ID: 26077380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-osteoporosis drug use: too little, too much, or just right? The HUNT study, Norway.
    Hoff M; Skurtveit S; Meyer HE; Langhammer A; Søgaard AJ; Syversen U; Skovlund E; Abrahamsen B; Forsmo S; Schei B
    Osteoporos Int; 2018 Aug; 29(8):1875-1885. PubMed ID: 29774403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.